APA (7th ed.) Citation

H, U., S, Y., K, K., M, T., A, K., K, T., . . . Y, F. (2025). Identification of poor prognostic factors using circulating extracellular vesicles in durvalumab consolidation therapy for locally advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 208, 108732. https://doi.org/10.1016/j.lungcan.2025.108732

Chicago Style (17th ed.) Citation

H, Utsumi, et al. "Identification of Poor Prognostic Factors Using Circulating Extracellular Vesicles in Durvalumab Consolidation Therapy for Locally Advanced Non-small Cell Lung Cancer." Lung Cancer (Amsterdam, Netherlands) 208 (2025): 108732. https://doi.org/10.1016/j.lungcan.2025.108732.

MLA (9th ed.) Citation

H, Utsumi, et al. "Identification of Poor Prognostic Factors Using Circulating Extracellular Vesicles in Durvalumab Consolidation Therapy for Locally Advanced Non-small Cell Lung Cancer." Lung Cancer (Amsterdam, Netherlands), vol. 208, 2025, p. 108732, https://doi.org/10.1016/j.lungcan.2025.108732.